Genesis Bioventures, Inc. Announced Today That the Company is Participating in an Audio Interview on Wallst.net on Friday, August 03, 2007
Genesis Bioventures zu myNews hinzufügen Was ist das?
Mr. Douglas C. Lane, CEO, stated today that Genesis Bioventures, Inc.
were invited to participate in an Audio Interview on Wallst.net
scheduled for Friday August 3, 2007 at 8:00 a.m. (PST). Some of the
talking points will be an overview of the Company, what Genesis
Bioventures, Inc. does and their target markets.
Expect to hear discussion of some trends in the market that he believes
will bolster Genesis Bioventures, Inc. prospects for near-term growth,
and the groundwork for long-term growth, including some milestones over
the next 12-18 months that investors should watch for.
Mr. Lane will also speak to what gives Genesis Bioventures, Inc. a
competitive edge in the market place, their management team , and some
of the key executives of the Company.
About Genesis Bioventures, Inc.
Genesis Bioventures, Inc. (OTCBB:GBIW) is a publicly traded biomedical
company that is commercializing two novel diagnostic products that meet
very large global unmet needs: the Mammastatin Serum Assay ("MSA"), a
breast cancer diagnostic risk assessment test, and the Rapid BSE Assay,
a fast and cost effective diagnostic test for on-site detection of Mad
Cow Disease (Bovine Spongiform Encephalopathy "BSE”).
The Mammastatin Serum Assay is offered through Biomedical Diagnostics,
LLC, a Genesis Bioventures’ wholly owned
subsidiary.
The Rapid BSE Assay is offered through Prion Developmental Laboratories ("PDL”),
a Genesis Bioventures subsidiary investment company. Both products are
at the commercial stage of development. Technology and product
development are completed. Commercial launch will occur upon closing of
the Company’s financing. GBI offers senior
executive management, corporate and business development, financial
management, PR, and investment financing management to both operating
companies.
Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act
of 1995: This release contains forward-looking information.
Statements that are not descriptions of historical facts are
forward-looking statements provided under the ``safe harbor'' protection
of the Private Securities Litigation Reform Act of 1995. Examples of
forward-looking statements are statements about anticipated financial or
operating results, financial projections, business prospects, future
product performance and other matters that are not historical facts.
Such statements often include words such as ``believes,'' ``expects,''
``anticipates,'' ``intends,'' ``plans,'' ``estimates'' or similar
expressions.
